Metraipolis › archive › dc_078f4f591eca

A minimal PBPK model to accelerate preclinical development of drugs against tuberculosis — Europe PMC PMID:38239195

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/38239195
DOI
10.3389/fphar.2023.1272091
License (as archived)
solo-consultazione
Archived
2026-10-08T07:52:59.917Z
SHA-256 of the archived text
cfb400b165305e61b945ebaf0323dce175ed7813d4d73fa57a27a5d026a37749
Stable URL of this page
https://metraipolis.com/documento/dc_078f4f591eca

How to cite

A minimal PBPK model to accelerate preclinical development of drugs against tuberculosis — Europe PMC PMID:38239195 — Europe PMC (en), https://europepmc.org/article/MED/38239195 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_078f4f591eca (Metraipolis archive dc_078f4f591eca, sha256 cfb400b165305e61b945ebaf0323dce175ed7813d4d73fa57a27a5d026a37749)
BibTeX
@misc{dc078f4f591eca,
  title = {A minimal PBPK model to accelerate preclinical development of drugs against tuberculosis — Europe PMC PMID:38239195},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/38239195},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_078f4f591eca; sha256 cfb400b165305e61b945ebaf0323dce175ed7813d4d73fa57a27a5d026a37749},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/38239195. Agents can read the archived copy with the MCP tool read_document.